期刊文献+

丙戊酸对AngⅡ诱导的心肌细胞肥大与HDAC2表达的抑制作用 被引量:1

Valproic acid inhibits cardiomyocyte hypertrophy and HDAC2 expressions induced by angiotensin II
下载PDF
导出
摘要 目的:观察组蛋白脱乙酰基酶抑制剂—丙戊酸(valproic acid,VPA)抑制心肌细胞肥大和组蛋白脱乙酰基酶2(histone deacetylase 2,HDAC2)的表达。方法:常规方法培养原代心肌细胞,分为5组:对照组、肥大组、低浓度VPA组(5×10-6mol/L)、中浓度VPA组(10-5mol/L)和高浓度VPA组(2×10-5mol/L)。给予血管紧张素Ⅱ(AngⅡ)刺激心肌细胞造成肥大后,给予不同浓度的VPA进行干预。AngⅡ作用24 h后,于相差显微镜下观察心肌细胞面积的变化。用RT-PCR检测HDAC2 mRNA的表达;免疫组化染色法检测HDAC2蛋白的表达。结果:经AngⅡ刺激后,在相差显微镜下可见心肌细胞面积变大,HDAC2 mRNA的水平增高,HDAC2蛋白表达亦增加。给予不同浓度的VPA后,上述指标随着VPA浓度的增加而逐渐下降(P<0.05)。结论:AngⅡ致心肌细胞肥大的过程中伴有HDAC2表达增加,给予HDAC抑制制后,可使心肌细胞面积减少,HDAC2表达减少,提示VPA可抑制心肌细胞的肥大,HDAC2有可能参与心肌细胞肥大的机制。 AIM: To observe the expression of histone deacetylase 2 (HDAC2) in hypertrophic cardiomyeytes induced by angiotensin Ⅱ (Ang Ⅱ) and to study the inhibitory role of valproic acid (VPA). METHODS: Cultured cardiomyocytes were treated with AngⅡ to induce hypertrophy, along with VPA of different concentrations. They were divided randomly into control group, hypertrophic group, and low (5×10^-6 mol/L), medium (10^-5 tool/L) and high concentration (2 ×10^-5 mol/L) group. Morphological changes of eardiomyocytes were observed under the contrast phase microscope, mRNA levels of HDAC2 were examined by reverse transcriptase polymerase chain reaction (RT-PCR). Protein expressions of HDAC2 were examined by immunohistochemistry. RESULTS: Stimulated by Ang Ⅱ, cardiomyoeytes were enlarged under the contrast phase microscope. After stimulation by AngⅡ, the mRNA level of HDAC2 and the protein expression of HDAC2 increased in the hypertrophic cardiocytes. Along with VPA, these data decreased accordingly as the VPA concentrations increased. CONCLUSION: Expression of HDAC2 increased in hypertrophic cardiomyocytes stimulated by Ang Ⅱ. HDAC2 may play a role in cardiocyte hypertrophy. VPA may inhibit cardiomyocyte hypertrophy and HDAC2 expressions.
出处 《心脏杂志》 CAS 2009年第5期639-642,共4页 Chinese Heart Journal
基金 黑龙江省卫生厅课题项目资助(2005-295)
关键词 组蛋白脱乙酰基酶2 血管紧张素Ⅱ 心肌细胞 肥大 丙戊酸 histone deacetylase 2 angiotensin Ⅱ cardiomyocyte hypertrophy valproic acid
  • 相关文献

参考文献9

  • 1Zhang CL, McKinsey TA, Chang S, et al. Class Ⅱ histone deacetylases act as signal-responsive repressors of cardiac hypertrophy[J]. Cell, 2002, 110(4):479-488.
  • 2Antos CL, McKinsey TA, Dreitz M, et al. Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors[J]. J Biol Chem, 2003, 278(31):28930-28937.
  • 3Kook H, Lepore JJ, Gitler AD, et al. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop[J]. J Clin Invest, 2003, 112(6):863-871.
  • 4陆莹,杨爽,马珊珊,李呼伦,于波.组蛋白脱乙酰基酶2在血管紧张素Ⅱ致心肌细胞肥大中的表达[J].中国地方病学杂志,2005,24(4):392-395. 被引量:1
  • 5刘红利,陈燕.组蛋白乙酰化/去乙酰化及其在恶性血液病中的研究进展[J].现代临床医学生物工程学杂志,2003,9(2):146-148. 被引量:2
  • 6Kong Y, Tannous P, Lu G, et al. Suppression of class Ⅰ and Ⅱ histone deacetylases blunts pressure-overload cardiac hypertrophy[J]. Circulation, 2006, 113(22):2579-2588.
  • 7Krmer OH, Zhu P, Ostendorff HP, et al. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2[J]. EMBO J, 2003, 22(13):3411-3420.
  • 8Lee TM, Lin MS, Chang NC, et al. Inhibition of histone deacetylase on ventricular remodeling in infarcted rats[J]. Am J Physiol Heart Circ Physiol, 2007, 293(2):H968-H977.
  • 9Zeng Y, Tang CM, Yao YL, et al. Cloning and characterization of the mouse histone deacetylase-2 gene[J]. J Biol Chem, 1998, 273(44):28921-28930.

二级参考文献22

  • 1王春梅,曹峰林,孙晶,赵立卓.肿瘤坏死因子的基因型与扩张型心肌病的相关性研究[J].中国地方病学杂志,2004,23(5):410-411. 被引量:4
  • 2周扬,翟俊民,王治伦,陈燕,吴劲.克山病病因研究进展[J].中国地方病学杂志,2004,23(5):496-498. 被引量:11
  • 3Hu JF, Oruganti- H, Vu TH, et al. The role of histone acetylation in the allelic expression of imprinted human insulin - like growth factor Ⅱ gene[J].Biochem Biophys Res Commun. 1998,251(2) :403.
  • 4Hongwu then, Lacombe L, Montgomery K et al. HATs on and beyond chromatin[M]. Current Opinion in Cell Biology Opinion in Cell Biology.2001,13;218.
  • 5Vigushin DM, Ohnmacht GA, Parkhurst ML,et al. Histone deacetylase inhibitors in cancer treatment[J]. Anticancer Drugs 2002 Jan ; 13 ( 1 ) : 1 - 13,2002 Jan;13(1) : 1.
  • 6Les. J Burke, Tong - On P, Marincola FM, et al. Rifkind. Histone Deacetylase Inhibitors: Inducers of Diffrentiation or Apoptosis of Transformed Cells[ J]. FASEB J,2000,14:1876.
  • 7Sasakawa Y, Naoe Y, Inoue T, et al. Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U - 937 cells in vitro and in vivo[J].Biochem Pharmacol 2002 Oct 1;64(7) :1079.
  • 8Buckley - AR, Nicolela MT, Drance SM, et al. Alterations in pim - 1 and c- myc expression associated with sodium butyrate - induced growth factor dependency in autonomous rat Nb2 lymphoms cells[J] .Cell - Growth - Differ. 1996 Dec; 7(12):1713.
  • 9Roder K, Kim KH, Sook Sul H. Induction of murine H - rev107 gene expression by growth srrest and histone acetylation: involvement of an Spl/Sp3- binding GC- box[J].Biochem Biophys Res Commun 2002 May 31;294(l) :63.
  • 10Piekarz RL, Piekaz RL, Robey R, Sandor V, et al. Inhibitor of histone deacetylation, depsipeptide (FR901228),in the treatment of peripheral and cutaneous T- cell lymphoma: a case report[J] .Blood 2001 Nov 1,98(9) :2865.

共引文献1

同被引文献3

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部